BBIO insider resale notice: trust 10b5-1 sales listed
Issuer filed a Form 144 reporting planned sales of Common Stock under 10b5-1 plans by trusts associated with Kumar Haldea.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Issuer filed a Form 144 reporting planned sales of Common Stock under 10b5-1 plans by trusts associated with Kumar Haldea. The filing lists multiple 10b5-1 dispositions of 20,000 shares each on dates including 03/12/2026, 03/13/2026, 04/09/2026, 04/10/2026, 05/07/2026, 05/08/2026, and a restricted stock unit entry dated 05/16/2026. Transactions were executed through Morgan Stanley Smith Barney LLC.
Insights
Form 144 lists repeated trust sales executed under 10b5-1 plans.
The excerpt documents multiple sales of Common Stock in 20,000-share increments by the Kumar Haldea Revocable Trust and the Kumar Haldea Family Irrevocable Trust on specific dates in 2026. Each row pairs a date with a 20,000-share disposition and an aggregate dollar amount.
These entries reflect planned dispositions reported via a Form 144 and routed through Morgan Stanley Smith Barney LLC; the filing constitutes a notice of proposed sale rather than confirmation of settlement amounts or remaining holdings.
Key Figures
Key Terms
10b5-1 regulatory
Form 144 regulatory
Restricted Stock Units financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does BBIO's Form 144 disclose about Kumar Haldea's transactions?
Which entities executed the sales reported in the Form 144 for BBIO?
Are the sales tied to restricted stock units in the filing?
Do the dollar amounts in the Form 144 represent proceeds per sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.